« Previous
Next »
Nuclear Medicine and Biology
Volume 37, Issue 8
, Pages 927-934
, November 2010
PEGylated N-methyl-S-methyl dithiocarbazate as a new reagent for the high-yield preparation of nitrido Tc-99m and Re-188 radiopharmaceuticals
References
- . High-yield synthesis of the terminal 188Re
N multiple bond from generator-produced [188ReO4]−. Nucl Med Biol. 2003;30:381–387 - . A new efficient method for the preparation of 99mTc-radiopharmaceuticals containing the Tc
N multiple bond. Int J Appl Radiat Isot. 1992;43:1329–1333 - . Synthesis and characterization of the new neutral myocardial imaging agent [99mTcN(noet)2] (noet=N-ethyl-N-ethoxydithiocarbamato). J Chem Soc Chem Commun. 1992;1354–1355
- . Synthesis and biodistribution of a new 99mTc nitrido complex for cerebral imaging. Nucl Med Biol. 2002;29(6):665–669
- Technetium(V)-nitrido complexes of dithiocarbazic acid derivatives. Reactivity of [99mTc
N]2+ core towards schiff bases derived from S-methyl dithiocarbazate. Crystal structures of [S-methyl 3-(2-hydroxyphenyl-methylene)dithiocarbazato]nitrido (triphenylphosphine)technetium(V) and bis (S-methyl 3-isopropylidenedithiocarbazato)nitridotecnetium(V). J Chem Soc Dalton Trans. 1988;1743–1749 - . Studies of technetium complexes. Use of the tetrachloronitridotechnetate(VI) anion for the preparation of nitrido complexes of technetium. Crystal structure of bis(8-quinolinethiolato)nitridotechnetium(V). Inorg Chem. 1986;25:150–155
- Co-ordination chemistry of S-methyl 2-methyldithiocarbazate and formation of [M
N]2+ (M=Tc or Re) species. J Chem Soc Dalton Trans. 1996;3105–3109 - Novel approach to the high-specific-activity labeling of small peptides with the technetium-99m fragment [99mTc(N)(PXP)]2+ (PXP=diphosphine ligand). Bioconj Chem. 2001;12(6):1035–1042
- . Ruthenium (II)-mediated reaction of phenylacetylene with primary amines to give ruthenium(II)-isonitrile complexes. Organometallics. 1995;14:3152–3153
- . Formation of the Tc
N multiple bond from the reaction of ammonium pertechnetate with S-methyl dithiocarbazate and its application to the preparation of technetium-99m radiopharmaceuticals. J Chem Soc Dalton Trans. 1990;3729–3733 - . Mixed ligand Tc- and Re-nitrido complexes for radiolabeling bioactive molecules. Recent Rev Devel Inorg Chem. 2000;2:89–98
- Reliable synthesis of asymmetrical nitrido Tc(V) and Re(V) heterocomplexes. In: Nicolini M, Mazzi U editor. Technetium, Rhenium and Other Metals in Chemistry and Nuclear Medicine. Padova, Italy: SGE Editoriali; 1999;p. 133–138
- Tc and Re nitrido asymmetrical heterocomplexes. A ‘2+2’ approach. In: Nicolini M, Mazzi U editor. Technetium, rhenium and other metals in chemistry and nuclear medicine. Padova, Italy: SGE Editoriali; 1999;p. 139–144
- Geometrically controlled selective formation of nitrido technetium(V) heterocomplexes with bidentate ligands. J Am Chem Soc. 2000;122:4510–4511
- . Effect of PEGylation on pharmaceuticals. Nat Rev Drug Discoveries. 2003;2:214–221
- . Protein, peptide and non-peptide drug PEGylation for therapeutical application: a review. Expert Opin Ther Pat. 2004;14:859–894
- Synthesis and biological evaluation of monocationic asymmetric 99mTc-nitride heterocomplexes showing high heart uptake and improved imaging properties. Journal of Nuclear Medicine. 2003;44(5):806–814
PII: S0969-8051(10)00309-4
doi: 10.1016/j.nucmedbio.2010.05.008
© 2010 Elsevier Inc. All rights reserved.
« Previous
Next »
Nuclear Medicine and Biology
Volume 37, Issue 8
, Pages 927-934
, November 2010
